FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Fred Apple

Research Profile

Chemicals & Drugs

Concepts & Ideas

Disorders

Anatomy

Procedures

Immunoassay

Phenomena

False Positive Reactions

Co-author Network

Publications

TOP 3
Vikram Palamalai; A Quinn Strobl; Lindsey C Thomas; Julie Kloss; Owen Middleton; Kelly Mills; Kalen N Olson; Fred S Apple
Superiority of postmortem liver fentanyl concentrations over peripheral blood influenced by postmortem interval for determination of fentanyl toxicity.
Stephen W Smith; Fred S Apple; Deborah B Diercks; Judd E Hollander; Peter A McCullough; Chadwick D Miller; John T Nagurney; Christian T Ruff; Jon W Schrock; Arturo Sesma; Adam J Singer; W Frank Peacock
Central versus local adjudication of myocardial infarction in a cardiac biomarker trial.
Fred S Apple; Lesly A Pearce; Stephen Smith; MaryAnn M Murakami
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Fred Apple (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Vikram Palamalai; A Quinn Strobl; Lindsey C Thomas; Julie Kloss; Owen Middleton; Kelly Mills; Kalen N Olson; Fred S Apple
Superiority of postmortem liver fentanyl concentrations over peripheral blood influenced by postmortem interval for determination of fentanyl toxicity.
Clinical biochemistry 2013;46(7-8):598-602.
2013: Stephen W Smith; Fred S Apple; Deborah B Diercks; Judd E Hollander; Peter A McCullough; Chadwick D Miller; John T Nagurney; Christian T Ruff; Jon W Schrock; Arturo Sesma; Adam J Singer; W Frank Peacock
Central versus local adjudication of myocardial infarction in a cardiac biomarker trial.
American heart journal 2013;165(3):273-279.e1.
2012: Fred S Apple; Lesly A Pearce; Stephen Smith; MaryAnn M Murakami
Delta changes for optimizing clinical specificity and 60-day risk of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome utilizing the ADVIA Centaur TnI-Ultra assay.
Clinical biochemistry 2012;45(10-11):711-3.
2012: Fred S Apple; MaryAnn M Murakami; Lesly A Pearce; Lyn M Steffen; Russell V Luepker
Increased cardiac troponin I as measured by a high-sensitivity assay is associated with high odds of cardiovascular death: the Minnesota Heart Survey.
Clinical chemistry 2012;58(5):930-5.
2012: Fred S Apple; Paul O Collinson
Analytical characteristics of high-sensitivity cardiac troponin assays.
Clinical chemistry 2012;58(1):54-61.
2011: Fred S Apple
A better understanding of the interpretation of postmortem blood drug concentrations.
Journal of analytical toxicology 2011;35(6):381-3.
2011: Fred S Apple
High-sensitivity cardiac troponin for screening large populations of healthy people: is there risk?
Clinical chemistry 2011;57(4):537-9.
2011: Fred S Apple; Stephen Smith; Lesly A Pearce; Karen M Schulz; Ranka Ler; MaryAnn M Murakami
Myeloperoxidase improves risk stratification in patients with ischemia and normal cardiac troponin I concentrations.
Clinical chemistry 2011;57(4):603-8.
2011: Fred S Apple
Biomarkers in aggregate.
Nature biotechnology 2011;29(3):236-7.
2010: Fred S Apple; Peter A Simpson; MaryAnn M Murakami
Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.
Clinical biochemistry 2010;43(12):1034-6.
2010: A Selcuk Adabag; Garry Peterson; Fred S Apple; Jack Titus; Richard King; Russell V Luepker
Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation.
American heart journal 2010;159(1):33-9.
2009: Fred S Apple
A new season for cardiac troponin assays: it's time to keep a scorecard.
Clinical chemistry 2009;55(7):1303-6.
2009: Fred S Apple; Lesly A Pearce; Stephen Smith; Jason M Kaczmarek; MaryAnn M Murakami
Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.
Clinical chemistry 2009;55(5):930-7.
2009: Fred S Apple
Cardiac biomarkers: establishing reference ranges and standardization of assays across laboratories for clinical practice.
Clinical biochemistry 2009;42(4-5):295.
2008: Fred S Apple; MaryAnn M Murakami; Ranka Ler; Dana Walker; Malcolm York
Analytical characteristics of commercial cardiac troponin I and T immunoassays in serum from rats, dogs, and monkeys with induced acute myocardial injury.
Clinical chemistry 2008;54(12):1982-9.
2008: Fred S Apple; Stephen Smith; Lesly A Pearce; Ranka Ler; MaryAnn M Murakami
Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
Clinical chemistry 2008;54(4):723-8.
2008: Fred S Apple; Stephen Smith; Lesly A Pearce; Ranka Ler; MaryAnn M Murakami; Marie-Odile Benoit; Camille Levy; Catherine Dumas; Jean-Louis Paul
Use of the bioMérieux VIDAS troponin I ultra assay for the diagnosis of myocardial infarction and detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
Clinica chimica acta; international journal of clinical chemistry 2008;390(1-2):72-5.
2008: Kristin N Luckenbill; Robert H Christenson; Allan S Jaffe; Johannes Mair; Jordi Ordonez-Llanos; Franca Pagani; Jillian Tate; Alan H B Wu; Ranka Ler; Fred S Apple
Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage.
Clinical chemistry 2008;54(3):619-21.
2007: Fred S Apple; Alan H B Wu; Allan S Jaffe; Mauro Panteghini; Robert H Christenson; Christopher P Cannon; Gary Francis; Robert L Jesse; David A Morrow; L Kristin Newby; Alan Storrow; W H Wilson Tang; Franca Pagani; Jillian Tate; Jordi Ordonez-Llanos; Johannes Mair
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine practice guidelines: Analytical issues for biomarkers of heart failure.
Circulation 2007;116(5):e95-8.
2007: W H Wilson Tang; Gary S Francis; David A Morrow; L Kristin Newby; Christopher P Cannon; Robert L Jesse; Alan Storrow; Robert H Christenson; Fred S Apple; Jan Ravkilde; Alan H B Wu
National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: Clinical utilization of cardiac biomarker testing in heart failure.
Circulation 2007;116(5):e99-109.
2007: Fred S Apple; Lesly A Pearce; Adrine Chung; Ranka Ler; MaryAnn M Murakami
Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.
Clinical chemistry 2007;53(5):874-81.
2007: Fred S Apple; Robert L Jesse; L Kristin Newby; Alan H B Wu; Robert H Christenson
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical issues for biochemical markers of acute coronary syndromes.
Circulation 2007;115(13):e352-5.
2007: David A Morrow; Christopher P Cannon; Robert L Jesse; L Kristin Newby; Jan Ravkilde; Alan Storrow; Alan H B Wu; Robert H Christenson; Fred S Apple; Gary Francis; Wilson Tang
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.
Clinical chemistry 2007;53(4):552-74.
2007: Fred S Apple; Robert L Jesse; L Kristin Newby; Alan H B Wu; Robert H Christenson; Christopher P Cannon; Gary Francis; David A Morrow; Jan Ravkilde; Alan Storrow; Wilson Tang; Allan S Jaffe; Johannes Mair; Jordi Ordonez-Llanos; Franca Pagani; Mauro Panteghini; Jillian Tate
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biochemical markers of acute coronary syndromes.
Clinical chemistry 2007;53(4):547-51.
2007: Fred S Apple; Lesly A Pearce; Patrick J Doyle; Angela P Otto; MaryAnn M Murakami
Cardiac troponin risk stratification based on 99th percentile reference cutoffs in patients with ischemic symptoms suggestive of acute coronary syndrome: influence of estimated glomerular filtration rates.
American journal of clinical pathology 2007;127(4):598-603.
2006: Robert H Christenson; Show-Hong Duh; Fred S Apple; Geza S Bodor; David M Bunk; Mauro Panteghini; Michael J Welch; Alan H B Wu; Stephen E Kahn
Toward standardization of cardiac troponin I measurements part II: assessing commutability of candidate reference materials and harmonization of cardiac troponin I assays.
Clinical chemistry 2006;52(9):1685-92.
2006: Fred S Apple; Adrine Y Chung; Mary Ellen Kogut; Susan Bubany; MaryAnn M Murakami
Decreased patient charges following implementation of point-of-care cardiac troponin monitoring in acute coronary syndrome patients in a community hospital cardiology unit.
Clinica chimica acta; international journal of clinical chemistry 2006;370(1-2):191-5.
2005: Fred S Apple; Alan H B Wu; Johannes Mair; Jan Ravkilde; Mauro Panteghini; Jillian Tate; Franca Pagani; Robert H Christenson; Martin Mockel; Oliver Danne; Allan S Jaffe
Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome.
Clinical chemistry 2005;51(5):810-24.
2005: Fred S Apple; Mauro Panteghini; Jan Ravkilde; Johannes Mair; Alan H B Wu; Jillian Tate; Franca Pagani; Robert H Christenson; Allan S Jaffe
Quality specifications for B-type natriuretic peptide assays.
Clinical chemistry 2005;51(3):486-93.
2005: Fred S Apple; MaryAnn M Murakami
Cardiac troponin and creatine kinase MB monitoring during in-hospital myocardial reinfarction.
Clinical chemistry 2005;51(2):460-3.
2004: Fred S Apple; MaryAnn M Murakami; Robert H Christenson; John L Campbell; Cary J Miller; Karl G Hock; Mitchell G Scott
Analytical performance of the i-STAT cardiac troponin I assay.
Clinica chimica acta; international journal of clinical chemistry 2004;345(1-2):123-7.
2004: Fred S Apple; Heidi E Quist; MaryAnn M Murakami
Diagnostic and prognostic value of cardiac troponin I assays in patients admitted with symptoms suggestive of acute coronary syndrome.
Archives of pathology & laboratory medicine 2004;128(4):430-4.
2004: Angelique Gagajewski; MaryAnn M Murakami; Julie Kloss; Michael Edstrom; Melissa Hillyer; Garry F Peterson; Janis Amatuzio; Fred S Apple
Measurement of chemical analytes in vitreous humor: stability and precision studies.
Journal of forensic sciences 2004;49(2):371-4.
2004: Mauro Panteghini; Thomas P J Linsinger; Alan H B Wu; Francesco Dati; Fred S Apple; Robert H Christenson; Johannes Mair; Heinz Schimmel
Standardization of immunoassays for measurement of myoglobin in serum. Phase I: evaluation of candidate secondary reference materials.
Clinica chimica acta; international journal of clinical chemistry 2004;341(1-2):65-72.
2004: Mauro Panteghini; Franca Pagani; Kiang-Teck J Yeo; Fred S Apple; Robert H Christenson; Francesco Dati; Johannes Mair; Jan Ravkilde; Alan H B Wu
Evaluation of imprecision for cardiac troponin assays at low-range concentrations.
Clinical chemistry 2004;50(2):327-32.
2003: Fred S Apple; Heidi E Quist; Patrick J Doyle; Angela P Otto; MaryAnn M Murakami
Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations.
Clinical chemistry 2003;49(8):1331-6.
2003: Fred S Apple; MaryAnn M Murakami; Heidi H Quist; Lesly A Pearce; Stacey Wieczorek; Alan H B Wu
Prognostic value of the Ortho Vitros cardiac troponin I assay in patients with symptoms of myocardial ischemia. Risk stratification using European Society of Cardiology/American College of Cardiology recommended cutoff values.
American journal of clinical pathology 2003;120(1):114-20.
2003: Angelique Gagajewski; Fred S Apple
Methadone-related deaths in Hennepin County, Minnesota: 1992-2002.
Journal of forensic sciences 2003;48(3):668-71.
2002: Fred S Apple; MaryAnn M Murakami; Lesly A Pearce; Charles A Herzog
Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease.
Circulation 2002;106(23):2941-5.
2002: Fred S Apple; Alan H B Wu; Allan S Jaffe
European Society of Cardiology and American College of Cardiology guidelines for redefinition of myocardial infarction: how to use existing assays clinically and for clinical trials.
American heart journal 2002;144(6):981-6.
2002: Fred S Apple; Heidi E Quist; Angela P Otto; Wendy E Mathews; MaryAnn M Murakami
Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race.
Clinical chemistry 2002;48(7):1097-100.
2002: Angelique Gagajewski; Gershwin K Davis; Julie Kloss; Gregory K Poch; Cynthia J Anderson; Fred S Apple
False-positive lysergic acid diethylamide immunoassay screen associated with fentanyl medication.
Clinical chemistry 2002;48(1):205-6.
2001: Fred S Apple; MaryAnn M Murakami; Mauro Panteghini; Robert H Christenson; Francesco Dati; Johannes Mair; Alan H B Wu
International survey on the use of cardiac markers.
Clinical chemistry 2001;47(3):587-8.
2001: Robert H Christenson; Show-Hong Duh; W R Sanhai; Alan H B Wu; V Holtman; P Painter; E Branham; Fred S Apple; M Murakami; D L Morris
Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study.
Clinical chemistry 2001;47(3):464-70.
2001: Robert H Christenson; Show-Hong Duh; Fred S Apple; G S Bodor; D M Bunk; Joseph J Dalluge; Mauro Panteghini; James D Potter; Michael J Welch; Alan H B Wu; S E Kahn
Standardization of cardiac troponin I assays: round Robin of ten candidate reference materials.
Clinical chemistry 2001;47(3):431-7.
2001: Mauro Panteghini; W Gerhardt; Fred S Apple; Francesco Dati; Jan Ravkilde; Alan H B Wu
Quality specifications for cardiac troponin assays.
Clinical chemistry and laboratory medicine : CCLM / FESCC 2001;39(2):175-9.
2001: Fred S Apple
Cardiac troponin assays: analytical issues and clinical reference range cutpoints.
Cardiovascular toxicology 2001;1(2):93-8.
2000: V Ricchiuti; W S Shear; Timothy D Henry; PR Paulsen; EA Miller; Fred S Apple
Monitoring plasma cardiac troponin I for the detection of myocardial injury after percutaneous transluminal coronary angioplasty.
Clinica chimica acta; international journal of clinical chemistry 2000;302(1-2):161-70.
2000: J R Beuerle; Hassan M E Azzazy; Fred S Apple; Show-Hong Duh; A Tan; Robert H Christenson
Performance characteristics of a new myoglobin microparticle enzyme immunoassay: a multicenter evaluation.
Clinical biochemistry 2000;33(7):595-8.
2000: Fred S Apple; F Philip Anderson; Paul O Collinson; Robert L Jesse; Michael C Kontos; M A Levitt; EA Miller; MaryAnn M Murakami
Clinical evaluation of the first medical whole blood, point-of-care testing device for detection of myocardial infarction.
Clinical chemistry 2000;46(10):1604-9.
2000: M Burt; D C Anderson; J Kloss; Fred S Apple
Evidence-based implementation of free phenytoin therapeutic drug monitoring.
Clinical chemistry 2000;46(8 Pt 1):1132-5.
2000: Edward B Stelow; V P Johari; S A Smith; JT Crosson; Fred S Apple
Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings.
Clinical chemistry 2000;46(4):577-81.
1999: V Ricchiuti; Fred S Apple
RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle.
Clinical chemistry 1999;45(12):2129-35.
1999: Fred S Apple
The specificity of biochemical markers of cardiac damage: a problem solved.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(11-12):1085-9.
1999: Fred S Apple
Tissue specificity of cardiac troponin I, cardiac troponin T and creatine kinase-MB.
Clinica chimica acta; international journal of clinical chemistry 1999;284(2):151-9.
1999: Mauro Panteghini; Fred S Apple; Robert H Christenson; Francesco Dati; Johannes Mair; Alan H B Wu
Use of biochemical markers in acute coronary syndromes. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. International Federation of Clinical Chemistry.
Clinical chemistry and laboratory medicine : CCLM / FESCC 1999;37(6):687-93.
1999: Fred S Apple; AJ Maturen; R E Mullins; P C Painter; M S Pessin-Minsley; R A Webster; J Spray Flores; R DeCresce; D J Fink; P M Buckley; J Marsh; V Ricchiuti; Robert H Christenson
Multicenter clinical and analytical evaluation of the AxSYM troponin-I immunoassay to assist in the diagnosis of myocardial infarction.
Clinical chemistry 1999;45(2):206-12.
1999: Fred S Apple; Robert H Christenson; Roland Valdes; A J Andriak; A Berg; Show-Hong Duh; Y J Feng; Saeed A Jortani; Nancy A Johnson; B Koplen; Kristin Mascotti; Alan H B Wu
Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction.
Clinical chemistry 1999;45(2):199-205.
1999: A Falahati; SW Sharkey; D Christensen; M McCoy; EA Miller; M A Murakami; Fred S Apple
Implementation of serum cardiac troponin I as marker for detection of acute myocardial infarction.
American heart journal 1999;137(2):332-7.
1999: Francesco Dati; Mauro Panteghini; Fred S Apple; Robert H Christenson; Johannes Mair; Alan H B Wu
Proposals from the IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): strategies and concepts on standardization of cardiac marker assays.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1999;230():113-23.
1999: Mauro Panteghini; Fred S Apple; Robert H Christenson; Francesco Dati; Johannes Mair; Alan H B Wu
Proposals from IFCC Committee on Standardization of Markers of Cardiac Damage (C-SMCD): recommendations on use of biochemical markers of cardiac damage in acute coronary syndromes.
Scandinavian journal of clinical and laboratory investigation. Supplementum 1999;230():103-12.
1999: Fred S Apple
Creatine kinase isoforms and myoglobin: early detection of myocardial infarction and reperfusion.
Coronary artery disease 1999;10(2):75-9.
1998: Fred S Apple; V Ricchiuti; EM Voss; P A Anderson; Arthur L Ney; Mark D Odland
Expression of cardiac troponin T isoforms in skeletal muscle of renal disease patients will not cause false-positive serum results by the second generation cardiac troponin T assay.
European heart journal 1998;19 Suppl N():N30-3.
1998: M D McLaurin; Fred S Apple; A Falahati; MaryAnn M Murakami; EA Miller; SW Sharkey
Cardiac troponin I and creatine kinase-MB mass to rule out myocardial injury in hospitalized patients with renal insufficiency.
The American journal of cardiology 1998;82(8):973-5.
1998: V Ricchiuti; EM Voss; Arthur L Ney; Mark D Odland; P A Anderson; Fred S Apple
Cardiac troponin T isoforms expressed in renal diseased skeletal muscle will not cause false-positive results by the second generation cardiac troponin T assay by Boehringer Mannheim.
Clinical chemistry 1998;44(9):1919-24.
1998: V Ricchiuti; SW Sharkey; MaryAnn M Murakami; EM Voss; Fred S Apple
Cardiac troponin I and T alterations in dog hearts with myocardial infarction: correlation with infarct size.
American journal of clinical pathology 1998;110(2):241-7.
1998: Fred S Apple; SW Sharkey; A Falahati; MaryAnn M Murakami; N Mitha; D Christensen
Assessment of left ventricular function using serum cardiac troponin I measurements following myocardial infarction.
Clinica chimica acta; international journal of clinical chemistry 1998;272(1):59-67.
1998: Robert H Christenson; Fred S Apple; D L Morgan; GL Alonsozana; Kristin Mascotti; M Olson; R T McCormack; Frank H Wians; JH Keffer; Show-Hong Duh
Cardiac troponin I measurement with the ACCESS immunoassay system: analytical and clinical performance characteristics.
Clinical chemistry 1998;44(1):52-60.
1997: Fred S Apple; A Falahati; PR Paulsen; EA Miller; SW Sharkey
Improved detection of minor ischemic myocardial injury with measurement of serum cardiac troponin I.
Clinical chemistry 1997;43(11):2047-51.
1997: V Ricchiuti; J Zhang; Fred S Apple
Cardiac troponin I and T alterations in hearts with severe left ventricular remodeling.
Clinical chemistry 1997;43(6 Pt 1):990-5.
1997: M D McLaurin; Fred S Apple; EM Voss; C A Herzog; SW Sharkey
Cardiac troponin I, cardiac troponin T, and creatine kinase MB in dialysis patients without ischemic heart disease: evidence of cardiac troponin T expression in skeletal muscle.
Clinical chemistry 1997;43(6 Pt 1):976-82.
1997: G S Bodor; L Survant; EM Voss; S Smith; D Porterfield; Fred S Apple
Cardiac troponin T composition in normal and regenerating human skeletal muscle.
Clinical chemistry 1997;43(3):476-84.
1997: Fred S Apple; SW Sharkey; P Hoeft; R Skeate; EM Voss; B A Dahlmeier; L M Preese
Prognostic value of serum cardiac troponin I and T in chronic dialysis patients: a 1-year outcomes analysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;29(3):399-403.
1996: M McLaurin; Fred S Apple; T D Henry; SW Sharkey
Cardiac troponin I and T concentrations in patients with cocaine-associated chest pain.
Annals of clinical biochemistry 1996;33 ( Pt 3)():183-6.
1996: Fred S Apple; A H Wu; R Valdes
Serum cardiac troponin T concentrations in hospitalized patients without acute myocardial infarction.
Scandinavian journal of clinical and laboratory investigation 1996;56(1):63-8.
1996: Fred S Apple; T D Henry; C R Berger; Y A Landt
Early monitoring of serum cardiac troponin I for assessment of coronary reperfusion following thrombolytic therapy.
American journal of clinical pathology 1996;105(1):6-10.
1995: G S Bodor; D Porterfield; EM Voss; S Smith; Fred S Apple
Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue.
Clinical chemistry 1995;41(12 Pt 1):1710-5.
1995: EM Voss; SW Sharkey; A E Gernert; MaryAnn M Murakami; R B Johnston; C C Hsieh; Fred S Apple
Human and canine cardiac troponin T and creatine kinase-MB distribution in normal and diseased myocardium. Infarct sizing using serum profiles.
Archives of pathology & laboratory medicine 1995;119(9):799-806.
1995: Fred S Apple; SW Sharkey; T D Henry
Early serum cardiac troponin I and T concentrations after successful thrombolysis for acute myocardial infarction.
Clinical chemistry 1995;41(8 Pt 1):1197-8.
1995: Fred S Apple; E Voss; L Lund; L Preese; C R Berger; T D Henry
Cardiac troponin, CK-MB and myoglobin for the early detection of acute myocardial infarction and monitoring of reperfusion following thrombolytic therapy.
Clinica chimica acta; international journal of clinical chemistry 1995;237(1-2):59-66.
1994: Fred S Apple; L Bilodeau; L M Preese; P Benson
Clinical implementation of a rapid, automated assay for assessing fetal lung maturity.
The Journal of reproductive medicine 1994;39(11):883-7.
1994: A H Wu; Roland Valdes; Fred S Apple; T Gornet; M A Stone; S Mayfield-Stokes; A M Ingersoll-Stroubos; B Wiler
Cardiac troponin-T immunoassay for diagnosis of acute myocardial infarction.
Clinical chemistry 1994;40(6):900-7.
1994: A Theologides; A M Ingersoll-Stroubos; Fred S Apple
TNF-alpha effect on oxygen free radical scavenging and generating enzymes in rat liver.
Biochemistry and molecular biology international 1994;33(1):205-10.
1992: L Bilodeau; D A Grotte; L M Preese; Fred S Apple
Glycerol interference in serum lipase assay falsely indicates pancreas injury.
Gastroenterology 1992;103(3):1066-7.
1992: Fred S Apple; L M Preese
Does increased lipase activity in serum imply damage to the pancreas?
Clinical chemistry 1992;38(4):602-3.
1992: L Bilodeau; L M Preese; Fred S Apple
Does low total creatine kinase rule out myocardial infarction?
Annals of internal medicine 1992;116(6):523-4.
1992: Fred S Apple
Acute myocardial infarction and coronary reperfusion. Serum cardiac markers for the 1990s.
American journal of clinical pathology 1992;97(2):217-26.
1991: Fred S Apple; J E Hyde; A M Ingersoll-Stroubos; A Theologides
Geographic distribution of xanthine oxidase, free radical scavengers, creatine kinase, and lactate dehydrogenase enzyme systems in rat heart and skeletal muscle.
The American journal of anatomy 1991;192(3):319-23.
1991: Fred S Apple; P Benson; L Preese; S Eastep; L Bilodeau; G Heiler
Lipase and pancreatic amylase activities in tissues and in patients with hyperamylasemia.
American journal of clinical pathology 1991;96(5):610-4.
1991: SW Sharkey; M M Murakami; S A Smith; Fred S Apple
Canine myocardial creatine kinase isoenzymes after chronic coronary artery occlusion.
Circulation 1991;84(1):333-40.
1990: Fred S Apple; L M Preese; L Riley; K L Gerken; F Van Lente
Financial impact of a rapid CK-MB-specific immunoassay on the diagnosis of myocardial infarction.
Archives of pathology & laboratory medicine 1990;114(10):1017-20.
1990: Fred S Apple; G Heiler; L Preese
Falsely increased CK-MB results obtained with the new reformulated CK-MB wash IV solution in the Stratus analyzer.
Clinical chemistry 1990;36(2):405-6.
1989: SW Sharkey; K J Elsperger; M Murakami; Fred S Apple
Canine myocardial creatine kinase isoenzyme response to coronary artery occlusion.
The American journal of physiology 1989;256(2 Pt 2):H508-14.
1989: Fred S Apple; P Benson; P A Abraham; T G Rosano; C E Halstenson
Assessment of renal function by inulin clearance: comparison with creatinine clearance as determined by enzymatic methods.
Clinical chemistry 1989;35(2):312-4.
1989: S J Eastep; P J Benson; L M Preese; Fred S Apple
Factitiously high sodium activities on the Ektachem 400 owing to interferences by high gamma-globulin concentrations.
Clinical chemistry 1989;35(2):333-4.
1988: SW Sharkey; Fred S Apple; K J Elsperger; R T Tilbury; S Miller; K Fjeldos; R W Asinger
Early peak of creatine kinase-MB in acute myocardial infarction with a nondiagnostic electrocardiogram.
American heart journal 1988;116(5 Pt 1):1207-11.
1988: Fred S Apple; L Preese; R Bennett; A Fredrickson
Clinical and analytical evaluation of two immunoassays for direct measurement of creatine kinase MB with monoclonal anti-CK-MB antibodies.
Clinical chemistry 1988;34(11):2364-7.
1988: Fred S Apple; Ylva Hellsten; P M Clarkson
Early detection of skeletal muscle injury by assay of creatine kinase MM isoforms in serum after acute exercise.
Clinical chemistry 1988;34(6):1102-4.
1988: Fred S Apple; C M Bandt
Liver and blood postmortem tricyclic antidepressant concentrations.
American journal of clinical pathology 1988;89(6):794-6.
1987: Fred S Apple; SW Sharkey; M Werdick; K J Elsperger; R T Tilbury
Analyses of creatine kinase isoenzymes and isoforms in serum to detect reperfusion after acute myocardial infarction.
Clinical chemistry 1987;33(4):507-11.